Karen-Leigh Edwards
Chief Tech/Sci/R&D Officer en OCULAR THERAPEUTIX, INC. .
Perfil
Karen-Leigh Edwards is currently the Senior Vice President-Technical Operations at Ocular Therapeutix, Inc. She previously worked as the Head-External Manufacturing & Operations at Alexion Pharmaceuticals, Inc. Edwards has a graduate degree from the University of London, a doctorate from the University of Kansas, and an undergraduate degree from the University Of The West Indies.
She also holds an MBA from the MIT Sloan School of Management.
Cargos activos de Karen-Leigh Edwards
| Empresas | Cargo | Inicio |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Chief Tech/Sci/R&D Officer | 28/09/2021 |
Antiguos cargos conocidos de Karen-Leigh Edwards.
| Empresas | Cargo | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Chief Operating Officer | - |
Formación de Karen-Leigh Edwards.
| University of London | Graduate Degree |
| University of Kansas | Doctorate Degree |
| University Of The West Indies | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Karen-Leigh Edwards
